DW1903

DRUG2 trials

Sponsors

Daewon Pharmaceutical Co., Ltd.

Conditions

GastritisGastritis AcuteGastritis Chronic

Phase 1

Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903

CompletedNCT05155072

Daewon Pharmaceutical Co., Ltd.Gastritis

Start: 2020-05-15End: 2020-09-07Updated: 2021-12-13

Phase 3

To Evaluate the Efficacy and Safety of DW1903 in Acute and Chronic Gastritis Patient

CompletedNCT05163756

Daewon Pharmaceutical Co., Ltd.Gastritis Acute, Gastritis Chronic

Start: 2020-11-25End: 2021-05-10Updated: 2021-12-20

Related Papers

Evaluation of the Efficacy and Safety of DW1903 in Patients with Gastritis: A Randomized, Double-Blind, Noninferiority, Multicenter, Phase 3 study

Gut and Liver2023-06-133 citations